Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

Glenmark Pharma has appointed Starcom for the media mandate of one of its brands, sources have confirmed to e4m. Further ...

After two years of steady gains, the stock market is now experiencing one of its sharpest corrections in recent history. US ...

Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

AbbVie made a $350 million upfront payment to Gubra for rights to the drug, called GUB014295. Gubra is also eligible to receive another $1.9 billion if certain development and sales milestones are met ...

Women’s Month, and especially International Women’s Day on March 8, is a time to recognize the groundbreaking contributions ...

The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...

A month has gone by since the last earnings report for Merck (MRK). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

The risk premia, or credit spreads, on euro bank bonds is widening due to increased market volatility, ABN Amro's Joost Beaumont said. "We expect spreads to continue to widen in the coming week, while ...